Vas Narasimhan, Novartis CEO, joins 'Money Movers' to discuss tariffs on pharmaceuticals, second quarter earnings and outlook on the pharma sector.

Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas Narasimhan joins Market Catalysts to discuss the company's growth drivers ...

Idorsia will publish its Half Year 2025 Financial Reporting on Wednesday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: ...

Time: 14:00 CEST / 13:00 BST / 08:00 EDT The call will start with presentations by senior management, including our new CEO Srishti Gupta, followed by a Q&A session.

Time: 14:00 CEST / 13:00 BST / 08:00 EDT The call will start with presentations by senior management, including our new CEO Srishti Gupta, followed by a Q&A session. Live Webcast (audio + slides): ...

Novartis (NYSE:NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year. During a CNBC interview, Narasimhan emphasized the ...

Idorsia will publish its Half Year 2025 Financial Reporting on Wednesday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. The call ...

One of the Gupta family’s Saxonwold homes sold for R3.3 million, far below its original value, while two other properties failed to meet minimum bids due to high rates and repair costs. The auction ...

DCP Srishti Gupta has issued strict directives, including continuous day and night patrolling near camps, langars, and major halts ...

The company is facing the possibility of steep U.S. tariffs on drugs, though CEO Vas Narasimhan has said that Novartis can manage their effects.